Hydroxyurea with dose escalation for primary stroke risk reduction in children with sickle cell anaemia in Tanzania (SPHERE): an open-label, phase 2 trial

Autor:	Emmanuela E Ambrose, Teresa S Latham, Primrose Songoro, Mwesige Charles, Adam C Lane, Susan E Stuber, Abel N Makubi, Russell E Ware, Luke R Smart
Rok vydání:	2023
Předmět:	Hematology
Zdroj:	The Lancet Haematology. 10:e261-e271
ISSN:	2352-3026
DOI:	10.1016/s2352-3026(22)00405-7
Databáze:	OpenAIRE
Externí odkaz:	https://explore.openaire.eu/search/publication?articleId=doi_________::6f56731b0c5f54f9cc9c9010b088fd5c https://doi.org/10.1016/s2352-3026(22)00405-7 Zobrazit plný text záznamu